Insulin aspart, recombinant Subcutaneous and Qmiiz ODT
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Qmiiz ODT and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: meloxicam
Brand name: Mobic, Qmiiz ODT, Vivlodex, Meloxicam Comfort Pac [DSC]
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-QNASL
- Insulin aspart, recombinant Subcutaneous-QNASL Nasal Spray
- Insulin aspart, recombinant Subcutaneous-Qroxin
- Insulin aspart, recombinant Subcutaneous-Qroxin Patch
- Insulin aspart, recombinant Subcutaneous-Qsymia
- Insulin aspart, recombinant Subcutaneous-Qtern
- Qmiiz ODT-Insulin degludec
- Qmiiz ODT-Insulin Degludec (U-100) Prefilled Pens
- Qmiiz ODT-Insulin Degludec (U-100) Vials
- Qmiiz ODT-Insulin Degludec (U-200) Prefilled Pens
- Qmiiz ODT-Insulin degludec and liraglutide
- Qmiiz ODT-Insulin degludec and liraglutide Subcutaneous